Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Partners Lp Bvf Insider Profile
4 Followers
Partners Lp Bvf, Ten Percent Owner at ESSA Pharma, holds 17.50M shares in ESSA Pharma (Ticker: EPIX). Most recently, Partners Lp Bvf ― shares of ESSA Pharma on ― for an estimated value of ―.
Partners Lp Bvf has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Partners Lp Bvf's holdings
Insider Roles
Ten Percent Owner
Roles that Partners Lp Bvf holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Partners Lp Bvf
Partners Lp Bvf's Trading History
List of latest transactions for each holding click on a transaction to see Partners Lp Bvf's performance on stock
You May Also Like
Partners Lp Bvf insider profile FAQ
What is the percentage of profitable transactions made by Partners Lp Bvf?
The percentage of profitable transactions made by Partners Lp Bvf is ―.
What is the average return per transaction made by Partners Lp Bvf?
The average return per transaction made by Partners Lp Bvf is ―.
What stocks does Partners Lp Bvf hold?
Partners Lp Bvf holds: EPIX stocks.
What was Partners Lp Bvf’s latest transaction?
Partners Lp Bvf latest transaction was an Uninformative Buy of ―.
What was Partners Lp Bvf's most profitable transaction?
Partners Lp Bvf’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Partners Lp Bvf's role in ESSA Pharma?
Partners Lp Bvf's role in ESSA Pharma is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.